| | Call Details | Laboratory Corporation of America Holdings Earnings Conference Call (Q4 2012) Scheduled
to start Fri, Feb 8, 2013, 9:00 am Eastern-- this event is ongoing now--
| | About Laboratory Corporation of America Holdings
(NYSE:LH) | Other Calls | | Laboratory Corporation of America Holdings, together with its subsidiaries, operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company's specialty tests and related services comprise viral load measurements, genotyping and phenotyping, and host genetic factors for infectious diseases; cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests for diagnostic genetics; oncology testing; clinical trials testing for pharmaceutical companies, which conducts clinical research trials on new drugs or diagnostic assays; forensic identity testing used in criminal proceedings and parentage evaluation services; allergy testing; and occupational testing for the detection of drug and alcohol abuse. Its customers comprise independent physicians and physician groups, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. As of December 31, 2009, the company operated 38 primary laboratories and approximately 1,500 patient service centers. It has a joint venture agreement with Duke University Medical Center to commercialize biomarkers. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|